TrialJournal of the American Society of Nephrology : JASN2017

Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.

Hiddo J L Heerspink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.